Description
The MAR-1 monoclonal antibody specifically recognizes Fc-epsilon RI-alpha (FceR1 alpha, also known as FcεR1α or FcER1a) which is likewise known as the IgE Fc receptor subunit alpha. FcεR1α is a type I transmembrane glycoprotein that is encoded by Fcer1a (Fc receptor, IgE, high affinity I, alpha polypeptide) which belongs to the Ig gene superfamily. As a single IgE-binding alpha subunit, FcεR1α complexes with signal transducing subunits including one beta subunit (FcεRIβ encoded by Ms4a2) and two disulfide-linked gamma subunits (FcεRIγ encoded by Fcer1g) to form the high-affinity receptor for IgE, Fc epsilon RI (FcεR1 or FcER1). FcεR1 is expressed on basophils and mast cells. Binding of cognate antigens (allergens) to FcεR1 with bound IgE antibodies leads to cellular activation and the release of mediators, including histamine and cytokines, that are responsible for allergic reactions. Tang et al. (2019) have reported that the MAR-1 antibody crossreacts with two other mouse Fc receptor chains, FcγRI (CD64) and FcγRIV (CD16-2), that are expressed by monocytes, macrophages, dendritic cells, or neutrophils. They suggested MAR-1 binding is specific for FcεRIa only on mast cells and basophils and that for other cell types reactive with the MAR-1 antibody, it may be appropriate to refer to these as MAR-1-positive (MAR-1+) cells.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
1. When using high concentrations of antibody, background binding of this dye to erythroid fragments produced by ammonium chloride-based lysis, such as with BD Pharm Lyse™ Lysing Buffer (Cat. No. 555899), has been observed when the antibody conjugate was present during the lysis procedure. This may cause nonspecific staining of target cells, such as leukocytes, which have bound the resulting erythroid fragments. This background can be mitigated by any of the following: titrating the antibody conjugate to a lower concentration, fixing samples with formaldehyde, or removing erythrocytes before staining (eg, gradient centrifugation or pre-lysis with wash). This background has not been observed when cells were lysed with BD FACS™ Lysing Solution (Cat. No. 349202) after staining.
2. The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
3. Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
4. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
5. An isotype control should be used at the same concentration as the antibody of interest.
6. Please observe the following precautions: We recommend that special precautions be taken (such as wrapping vials, tubes, or racks in aluminum foil) to protect exposure of conjugated reagents, including cells stained with those reagents, to any room illumination. Absorption of visible light can significantly affect the emission spectra and quantum yield of tandem fluorochrome conjugates.
7. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
8. For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
9. Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
10. Cy is a trademark of Global Life Sciences Solutions Germany GmbH or an affiliate doing business as Cytiva.
11. For U.S. patents that may apply, see bd.com/patents.
Specifications

General

SourceMouse KLK7, amino acids (Gln22 - Arg249) (Accession# NM_011872), with a C-terminal 8His tag was expressed in 293E cells.
Molecular MassThe 241 amino acid recombinant protein has a predicted molecular mass of approximately 26.5 kD. The protein migrates at approximately DTT-reducing and non-reducing conditions at 34-40 kD and 30-35 kD respectively by SDS-PAGE.
Purity>95%, as determined by Coomassie stained SDS-PAGE.
Formulation0.22 µm filtered protein solution is in 20 mM Tris, 0.3 M NaCl, pH 7.5.
Endotoxin LevelLess than 1.0 EU per µg of protein as determined by the LAL method.
Concentration10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & HandlingUnopened vial can be stored at -70°C for six months. For maximum results, quick spin vial prior to opening. Avoid repeated freeze/thaw cycles.
ActivityMouse KLK7 cleaves the peptide substrate Mca-RPKPVE-Nval-WRK(Dnp)-NH2 with a specific activity value of > 50 pmol/µg/min.
ApplicationBioassay
Application NotesThis protein is in the latent form and needs to be activated for bioassay. BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at [email protected].
StructureTrypsin-like serine protease.
DistributionKeratinocytes.
FunctionSkin desquamation of the stratum cornium. Inhibited by Zn2+, Cu2+, and the lymphoepithelial Kazal-type related inhibitor. Activated by KLK5 and induced by estrogens and glucocorticoids in a breast carcinoma cell line.
InteractionCorneocytes.
Ligand/ReceptorKLK7 directly cleaved CDSN and DSC1; Serpin A12.
BioactivityDegradation of corneodesmosomes in skin desquamation of the stratum corneum.
Biology AreaStem Cells
Molecular FamilyEnzymes and Regulators
Antigen References1. Hansson L, et al. 1999. J. Invest. Dermatol. 113:152. 2. Caubet C, et al. 2004. J. Invest. Dermatol. 122:1235. 3. Olsson AY, et al. 2004. Genomics 84:147. 4. Deraison C, et al. 2007. Mol. Biol. Cell. 18:3607. 5. Johnson SK, et al. 2007. Cancer 109:1811. 6. Emami N, Diamandis EP. 2008. J. Biol. Chem. 6:3031-41. 7. Lin TK, et al. 2012. J. Invest. Dermatol. 132:2430. 8. Haftek M, et al. 2015. Cell Tissue Res. 360:483. 9. Yu Y, et al. 2015. J. Biol. Chem. 290:17762.
Gene ID23993
UniProtView information about KLK7 on UniProt.org
Regulatory StatusRUO
Other NamesKallikrein-7, mK7, Serine protease 6, Stratum corneum chymotryptic enzyme (SCCE)